Dendrobium Huoshanense Suppository in Rectal Cancer
Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
To evaluates the role of Dendrobium Huoshanense Suppository for radiation proctitis in
locally advanced rectal cancer treated by capecitabine and irinotecan based neoadjuvant
chemoradiation.